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Impulsivity is a personality trait characterized byacting suddenly in an unplanned manner in order to
satisfy a desire without consideration for the conse-
quences of such behavior. There are several
psychiatric disorders that include the term impulsiv-
ity as a criterion and, therefore, it has been
suggested that impulsivity may be an important phe-
notype that may link a number of different
behavioral disorders, including substance abuse.
This study’s aims were to determine if a significant
association could be detected between the (AAT)n
triplet repeat polymorphism as well as 5 single
nucleotide polymorphisms (SNPs) in or near the
CNR1 receptor gene and impulsivity in Southwest
California ‘Mission’ Indians (SWC). Impulsivity was
assessed using a scale derived from the Maudsley
personality inventory, and blood samples were col-
lected for DNA analyses from 251 individuals
recruited from local Indian reservations. The esti-
mated heritability (h2) for the impulsivity phenotype
was 0.20 + 0.12 (p < .004). Impulsivity was signifi-
cantly associated with the 6-repeat allele of the
triplet repeat polymorphism (AATn/A6; p < .0001), as
well as four SNPs in or near the CNR1 receptor
gene: rs1535255 (p = .001), rs2023239 (p = .004),
rs1049353 (p < .001) and rs806368 (p < .0006).
These studies provide data to suggest that the
CNR1 receptor gene may be significantly associated
with impulsivity in SWC Indians.
The finding and localization of cannabinoid receptors
in the brain (Bidaut-Russel et al.,1990; Herkenham et
al.,1990; Howlett, 2002; Matsuda et al.,1990), the
genetic and physical mapping of cannabinoid receptor
genes (Hoehe et al.,1991) and characterization of the
endogenous cannabinoids (for reviews see Fride,
2002; Iversen et al.,2003; Onaivi et al.,2002;
Petrocellis et al., 2004; van der Stelt & Di Marzo,
2003) and their metabolism (Fowler et al., 2001),
have opened up new areas of research by which to
identify potential biologic/genetic mediators of risk
for, and consequences of, substance use disorders.
There have been some promising findings in asso-
ciation studies of candidate genes related to
endocannabinoids. A polymorphic triplet repeat
marker of the human cannabinoid receptor gene
(CNR1) has been identified (Dawson, 1995), and has
been demonstrated to be of functional relevance
(Zhang et al., 2005). In one study, the number of
intravenous drugs used was found to be significantly
greater for individuals carrying a genetic variant of
the CNR1 gene, the > 5/> 5 genotype, than for other
genotypes (Comings et al., 1997). It has also been
associated with attention deficit/hyperactivity disor-
der in Spanish male alcoholic patients (Ponce et al.,
2003). Additionally, an association between the
CNR1 > 5 repeat alleles and decreased amplitude of
the P300 event-related potential (ERP) component
was also found (Johnson et al., 1997), further sup-
porting the importance of intermediate phenotypes in
identifying genetic risk factors for drug abuse.
Several single nucleotide polymorphisms (SNPs), in
or around the CNR1 receptor gene, have also been
reported to be associated with drug abuse related
phenotypes. A 5’ CNR1 ‘TAG’ haplotype (rs806379-
rs1535255-rs2023239) was found to display
significant allelic frequencies differences between sub-
stance abusers and controls in European-American,
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African American and Japanese samples (Zhang et al.,
2004). The 1359A/G polymorphism (rs1049353) in the
coding exon of CNR1 (exon 4) has also been
associated with vulnerability to alcohol withdrawal
delirium (Schmidt et al., 2002). Additionally, the
rs806380 SNP located in intron 2 of the CNR1 gene
was significantly associated with developing one or
more cannabis dependence symptoms (Hopfer et al.,
2006), and the (AAT)n triplet repeat polymorphism
nearby the CNR1 gene was found to be associated
with cocaine addiction in an African-Caribbean popu-
lation (Ballon et al., 2006). However, several studies
have also failed to find association of the CNR1
receptor polymorphism and substance dependence
phenotypes (Herman et al., 2006; Li et al., 2000;
Preuss et al., 2003).
One reason for a lack of consensus is that the
various studies used different genetic markers in their
association studies. Another is that different phenotypes
were used and different ethnic populations were evalu-
ated. One phenotype that may link substance
dependence and other select axis-1 disorders is impul-
sivity. Impulsivity is a personality trait characterized by
acting suddenly in an unplanned manner in order to
satisfy a desire without consideration for the conse-
quences of such behavior. There are several psychiatric
disorders that include the term impulsivity as a crite-
rion, such as substance use disorders, paraphilias,
conduct disorder and antisocial personality disorder,
attention deficit/hyperactivity disorder, borderline per-
sonality disorder, pathological gambling, pyromania
and kleptomania, and so on. Therefore, it has been sug-
gested that impulsivity may be an important phenotype
that may link a number of different behavioral disor-
ders including substance abuse (Kreek et al., 2005).
Genetic studies of complex phenotypes often have
advantages when they are conducted in well-defined
populations, such as Native American tribes living on
reservations (Lander & Schork, 1994). The present
report is part of a larger study exploring risk factors
for substance dependence among Native American
Indians residing in southwest California (Ehlers et al.,
1998, 1999, 2001, 2004a, 2004b, 2006; Garcia-
Andrade et al., 1997; Wall et al., 1997, 2003). The
lifetime prevalence of substance dependence in this
Indian population is high and evidence for heritability
and linkage to specific chromosome locations has been
demonstrated (Ehlers & Wilhelmsen, 2005, 2006,
2007; Ehlers et al., 2004b; Wilhelmsen & Ehlers,
2005). The purpose of the present set of analyses was
to determine if a significant association could be
detected between the (AAT)n triplet repeat polymor-
phism, as well as 5 SNPs in or near the CNR1
receptor gene and impulsivity in this population.
Methods
Participants, known collectively as Southwest
California (SWC) Indians (also known as ‘Mission
Indians’), who were of mixed heritage but at least one-
sixteenth Native American, were recruited from eight
geographically contiguous reservations with a total
population of about 3000 individuals. They were
recruited using a combination of a venue-based
method (Kalton & Anderson 1986; Muhib et al.,
2001) and a respondent-driven procedure
(Heckathorn, 1997), as described previously (see
Ehlers et al., 2004a, 2004c). To be included in the
study, a participant had to be a SWC Indian between
the age of 18 and 70 without major medical problems
that would preclude mobility.
Potential participants gave written informed
consent, and responded to a screening questionnaire
that was used to gather information on demographics,
personal medical history, ethnicity, and detailed mea-
sures of substance abuse history (Schuckit, 1985), and
weight & height. Each participant also completed an
interview with the Semi-Structured Assessment for the
Genetics of Alcoholism (SSAGA; Bucholz et al., 1994)
that was used to make diagnoses (American Psychiatric
Association, 1994). Impulsivity was assessed using a
scale from the Maudsley personality inventory (Eaves
& Eysenck, 1975). While impulsivity is not one of the
Maudsley’s primary personality dimensions, the
Impulsiveness questionnaire of the Eysenck Personality
Scale (Eysenck & Eysenck, 1991) is frequently used as
a measure of impulsiveness and contains items derived
from both the Extraversion and Psychoticism dimen-
sions (Dawe & Loxton, 2004). A participant scored
positively on this scale if they endorsed the following 7
items: Do you long for excitement? Are you usually
carefree? Do you generally do and say things quickly
without stopping to think? Would you do almost any-
thing for a dare? Do you often do things on spur of the
moment? When people shout at you, do you shout
back? Do you like doing things in which you have to
act quickly? They scored negatively by endorsing the
following two items: Do you stop and think things over
before doing anything? Are you slow and unhurried in
the way you move?
Two hundred and fifty-one (251) individuals had
both genotype and phenotype data for this analyses.
Deoxyribonucleic acid (DNA) was isolated from
whole blood using an automated DNA extraction
procedure, genotyping was done as previously
described (Wilhelmsen et al., 2003). The total addi-
tive genetic heritability (h2) and its standard error
were estimated for the impulsivity phenotype using
SOLAR (http://www.sfbr.org/solar/). The (AAT)n
triplet repeat polymorphism and five single nucleotide
polymorphisms (SNPs) in or near the CNR1 receptor
were genotyped. The SNPs were selected based on the
information available at the time from previous
CNR1 association studies: the 3 SNPs that form the
‘TAG’ haplotype were selected based on the associa-
tion findings presented by Zhang et al. (2004), and
the 1359G/A exon 4 silent mutation (Thr453Thr)
from the group of Schmidt et al. (2002). Additionally,
the (AAT)n copy number was recoded (AATn/45) to
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investigate the ≥5/≥5 repeat genotype findings of
Comings et al. (1997), and to examine the affect of
the 6-repeat allele *(AATn/A6). The polymorphisms
typed, and their locations in relation to the CNR1
gene, are shown in Figure 1. Pair-wise marker-marker
linkage disequilibrium (LD), excluding the (AAT)n
triplet repeat, was assessed using the r2 statistic in
Haploview 4.0 (Barrett et al., 2005), and is graphi-
cally presented in Figure 1.
All primers, probes, and reagents were pur-
chased from ABI (Applied Biosystems, Foster City,
CA). SNPs [hCV1652584 (rs806379), hCV8943758
(rs1535255), hCV11600616 (rs2023239),
hCV1652590 (rs1049353) and hCV8943804
(rs806368)] were genotyped using TaqMan™ fluo-
rescence 5’ exonuclease technology, and genotypes
were determined on an ABI 7900HT Fast Real-Time
PCR System, using the allelic discrimination mode.
The (AAT)n triplet repeat polymorphism was geno-
typed using the following primers: FWD
5’6FAM-GCTGCTTCTGTTAACCCTGC -3’; and
REV 5’-TACATCTCCGTGTGAT GTTCC-3’. PCR
fragments containing the (AAT)n polymorphism
were analyzed using an ABI 3730 DNA Sequencer
and the repeat size was determined with
GeneMapper v3.5 software (ABI).
The total additive genetic variance (heritability, h2)
and its standard error were estimated for the impulsivity
phenotype using SOLAR (http://www.sfbr.org/solar/).
Two methods of genetic association analyses, that gave
highly correlated results, were employed. In the first
approach, the number of copies of the minor allele of
each individual was used as a covariate in a variance
component analysis, as implemented in SOLAR
v2.0.4 (Almasy & Blangero, 1998). The statistical sig-
nificance of the ability of the covariate to explain
phenotypic variance was determined. In the alterna-
tive strategy, a mixed model for general logistic
regression, as implemented in SAS statistical software,
was employed to assess the significance of genotype,
taking into account the non-independence of subjects
within families. The results reported are for the vari-
ance component analysis. To account for multiple
comparisons significance was set at the p < .01 level.
Results
The demographic characteristics of the sample are
virtually equivalent to the United States (US) census
data for these tribes and have been presented previ-
ously (see Ehlers et al., 2004b). The mean age of the
sample was 30.2 (± 0.7) yrs, there were 110 males
and 141 females with a mean of 11.5(0.1) yrs of edu-
cation, 60% of the sample was over 50% Native
American heritage as estimated by their federal
Indian blood quantum, and 55% reported income of
less than $20,000 per annum.
The estimated heritability (h2) for the impulsivity
phenotype was 0.20 ± 0.12 (p < .004). Impulsivity
was significantly associated with the triplet repeat
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polymorphism, as well as four SNPs in or near the
CNR1 receptor gene (p < .01; see table 1). Table 1
also lists the gene location of the polymorphisms and
minor allele frequencies for this SWC Indian popula-
tion, as well as 4 reference populations for
comparison. The 5 SNPs exhibited low to high
linkage disequilibrium (r2), comprising of one LD
block spanning exons 3 and 4, as shown in Figure 1.
Pairwise LD, using the D’ statistic also indicated a
region of complete LD (D’ = 1.0) 5’ to exon 3
between rs806379 and rs1535255 (data not shown).
This is consistent with LD data from the HapMap
database for CEPH families of European origin in
which two regions of moderate to high LD exist.
Discussion
Both substance dependence and behavioral control
disorders, such as conduct disorder and adult antiso-
cial personality disorder, have been shown to have a
significant genetic component to their etiology
(Button et al., 2005, 2006; Cloninger et al., 1981;
Grove et al., 1990; Heath et al., 1997; Kendler et al.,
1992, 2003; Prescott & Kendler, 1999; Slutske
2001). Behavioral genetics studies have the advan-
tage in being one of the strongest methods for
determining whether or not comorbidity among psy-
chopathological conditions is due to common
etiologies and/or pathologies associated with the dis-
orders. Complex traits like substance dependence
and impulsivity may be influenced by a number of
genes that may be specific to the etiology of those
disorders, or could overlap with other neurobehav-
ioral disorders.
Significant evidence for a heritable component
for impulsivity in this study and other substance
dependence related traits, in previous studies, have
been found in this SWC Indian population (Ehlers
& Wilhelmsen, 2005, 2006, 2007; Ehlers et al.,
2004b, 2007; Wilhelmsen & Ehlers, 2005).
Although heritability for the impulsivity trait was
only found to be modest in this population (0.20) it
was similar to what has been reported previously
(0.36) in a primary European ancestry twin sample
using a similarly derived impulsivity scale (Eaves &
Eysenck, 1975).
Impulsivity was significantly associated with the
6-repeat allele of the triplet repeat polymorphism
(AATn/A6), as well as four SNPs in or near the
CNR1 receptor gene in this SWC Indian population
sample. The finding of an association of impulsivity
with the triplet repeat polymorphism in SWC Indians
is consistent with findings by others who have
reported this polymorphism to be associated with:
the number of IV drugs used (Comings et al., 1997),
ADHD in alcoholic patients (Ponce et al., 2003),
cocaine addiction in Afro-Caribbeans (Ballon et al.,
2006), and decreased P300 ERP component ampli-
tudes (Johnson et al., 1997). Additionally, the finding
of significant associations with the four SNPs in or
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Exon:   1   2  3  4 
Figure 1
A schematic representation of the human CNR1 gene structure and linkage disequilibrium.
The (AAT)n triplet repeat and 5 single nucleotide polymorphisms (SNPs) analyzed in this study are shown in relation to their location across the
26.1 Kb CNR1 gene. Exons are numbered (1 to 4) and the relative exon size is denoted by the width of the horizontal boxes. The coding region of
exon 4 is indicated by the dark grey shading. Exons 1 to 3 were proposed as exons by Zhang et al. (2004). Pair-wise linkage disequilibrium (LD)
between the five SNPs, as measured by the r2 statistic, is graphically presented beneath the gene structure. Regions of low to high LD are
represented by light grey to black shading, respectively.
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near the CNR1 receptor gene are consistent with the
findings of Zhang et al., (2004) who found a 5’
CNR1 ‘TAG’ haplotype (rs806379-rs1535255-
rs2023239) to display significant allelic frequency
differences between substance abusers and controls
in European–American, African American, and
Japanese samples.
However, several studies have also failed to find
association of the CNR1 receptor polymorphism and
substance dependence phenotypes (Herman et al.,
2006; Li et al., 2000; Preuss et al., 2003). One
reason for a lack of consensus is that the various
studies used different genetic markers in their associ-
ation studies. Another is that different phenotypes
were used and different ethnic populations were eval-
uated. For instance, Pruess et al. (2003) found no
association with 1359A/G (rs1049353) and alco-
holism-related phenotypes, in particular, severe
alcohol withdrawal, in Caucasians from southern
Germany. Whereas Zhang et al. (2004) found an
association with the TAG haplotype and polysub-
stance abuse in three populations (African American,
European, Japanese).
In conclusion, these data represent the first asso-
ciation analysis of an impulsive behavior phenotype
with the CNR1 receptor gene. The results corrobo-
rated the possible importance of the relationship
between the (AAT)n triplet repeat polymorphism and
substance abuse related phenotypes, as well as SNPs
highlighted in prior studies of substance dependence
phenotypes and also identify new SNPs of potential
importance. The results of this study should,
however, be interpreted in the context of several limi-
tations. First, the findings may not generalize to
other Native Americans or represent all SWC
Indians. Second, comparisons of association findings
to non-Indian populations may be limited by differ-
ences in a host of potential genetic and
environmental variables. Finally, because this popula-
tion has significant admixture, estimates of allele
frequencies may produce biased results. Despite these
limitations, this report represents an important step
in an ongoing investigation to understand the genetic
determinants associated with the development of
substance use disorders in this high risk and under-
studied ethnic group.
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